Mantile F, Trovato M, Santoni A, Barba P, Ottonello S, De Berardinis P, et al. Alum and squalene-oil-in-water emulsion enhance the titer and avidity of anti-A? antibodies induced by multimeric protein antigen (1-11)E2, preserving the Igg1-skewed isotype distribution. PLoS ONE. 2014;9:e101474 pubmed publisher

Lin S, Lin K, Lin P, Huang C, Chang C, Lee Y, et al. Plasma amyloid assay as a pre-screening tool for amyloid positron emission tomography imaging in early stage Alzheimer's disease. Alzheimers Res Ther. 2019;11:111 pubmed publisher

Lue L, Kuo Y, Sabbagh M. Advance in Plasma AD Core Biomarker Development: Current Findings from Immunomagnetic Reduction-Based SQUID Technology. Neurol Ther. 2019;8:95-111 pubmed publisher

Gary C, Lam S, Herard A, Koch J, Petit F, Gipchtein P, et al. Encephalopathy induced by Alzheimer brain inoculation in a non-human primate. Acta Neuropathol Commun. 2019;7:126 pubmed publisher

Hudry E, Klickstein J, Cannavo C, Jackson R, Muzikansky A, Gandhi S, et al. Opposing Roles of apolipoprotein E in aging and neurodegeneration. Life Sci Alliance. 2019;2: pubmed publisher

Ceyzériat K, Ben Haim L, Denizot A, Pommier D, Matos M, Guillemaud O, et al. Modulation of astrocyte reactivity improves functional deficits in mouse models of Alzheimer's disease. Acta Neuropathol Commun. 2018;6:104 pubmed publisher

Fan L, Tzen K, Chen Y, Chen T, Lai Y, Yen R, et al. The Relation Between Brain Amyloid Deposition, Cortical Atrophy, and Plasma Biomarkers in Amnesic Mild Cognitive Impairment and Alzheimer's Disease. Front Aging Neurosci. 2018;10:175 pubmed publisher

Lue L, Guerra A, Walker D. Amyloid Beta and Tau as Alzheimer's Disease Blood Biomarkers: Promise From New Technologies. Neurol Ther. 2017;6:25-36 pubmed publisher

Chiu M, Yang S, Horng H, Yang C, Chen T, Chieh J, et al. Combined plasma biomarkers for diagnosing mild cognition impairment and Alzheimer's disease. ACS Chem Neurosci. 2013;4:1530-6 pubmed publisher

Petiet A, Delatour B, Dhenain M. Models of neurodegenerative disease - Alzheimer's anatomical and amyloid plaque imaging. Methods Mol Biol. 2011;771:293-308 pubmed publisher

Olah J, Vincze O, Virok D, Simon D, Bozso Z, Tökési N, et al. Interactions of pathological hallmark proteins: tubulin polymerization promoting protein/p25, beta-amyloid, and alpha-synuclein. J Biol Chem. 2011;286:34088-100 pubmed publisher

Restrepo L, Stafford P, Magee D, Johnston S. Application of immunosignatures to the assessment of Alzheimer's disease. Ann Neurol. 2011;70:286-95 pubmed publisher

Jordão J, Ayala Grosso C, Markham K, Huang Y, Chopra R, McLaurin J, et al. Antibodies targeted to the brain with image-guided focused ultrasound reduces amyloid-beta plaque load in the TgCRND8 mouse model of Alzheimer's disease. PLoS ONE. 2010;5:e10549 pubmed publisher

Law A, Gauthier S, Quirion R. Say NO to Alzheimer's disease: the putative links between nitric oxide and dementia of the Alzheimer's type. Brain Res Brain Res Rev. 2001;35:73-96 pubmed